5-(3-methyl-1-triazeno)imidazole-4-carboxamide has been researched along with 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gescher, A; Quarterman, CP; Slack, JA; Tsang, LL | 1 |
Babudri, N; Bartoli-Klugmann, F; Montibragadin, C; Pani, B; Tamaro, M; Venturini, S | 1 |
Ames, MM; Reid, JM; Rios, R; Safgren, SL | 1 |
Ames, MM; Easterling, TR; Hays, K; Hebert, MF; Kantrowitz-Gordon, I; Kaplan, HG; Kayode, O; Kumar, AR; Reid, JM; Safgren, SL | 1 |
4 other study(ies) available for 5-(3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide
Article | Year |
---|---|
Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
Topics: Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Dacarbazine; Lymphoma; Mice; Prodrugs; Temozolomide; Tumor Cells, Cultured | 1991 |
In vitro mutagenic activity of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in eukaryotic and prokaryotic cells.
Topics: Animals; Cell Count; Cell Line; Cricetinae; Cricetulus; Dacarbazine; Dose-Response Relationship, Drug; Escherichia coli; Mutagenicity Tests; Mutation; Salmonella typhimurium | 1982 |
Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide.
Topics: Chromatography, High Pressure Liquid; Clinical Trials, Phase II as Topic; Dacarbazine; Drug Stability; Humans; Models, Chemical; Reproducibility of Results | 2001 |
Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
Topics: Administration, Intravenous; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Dacarbazine; Doxorubicin; Drug Monitoring; Female; Hodgkin Disease; Humans; Infant, Newborn; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome; Vinblastine | 2018 |